⌘K

Login Start Free

Home/Filings/4/0001278333-04-000001

4//SEC Filing

ZHABILOV HARRY 4

Accession 0001278333-04-000001

CIK 0001091326other

View on SEC.gov Company Profile

Filed

Oct 21, 8:00 PM ET

Accepted

Oct 22, 2:08 PM ET

Size

22.7 KB

Accession

0001278333-04-000001

Insider Transaction Report

Form 4

Period: 2004-06-04

VIRAL GENETICS INC /DE/VRAL

DirectorExec. VP10% Owner

Transactions

Award
employee stock option
2004-06-04+1,800,000→ 4,100,000 total
Exercise: $0.45Exp: 2008-05-31→ common stock (1,800,000 underlying)
Other
common stock
2004-08-13+2,966,380→ 7,893,679 total
Award
common stock
2004-09-20+4,927,299→ 7,893,679 total
Award
common stock warrant
2004-09-20+4,927,299→ 4,927,299 total
Exercise: $0.40Exp: 2009-09-19→ common stock (4,927,299 underlying)
Award
stock option
2004-09-20+99,708→ 99,708 total
Exercise: $0.52Exp: 2006-09-19→ common stock (99,708 underlying)
Other
convertible note due
2004-08-05
Exercise: $0.30Exp: 2008-05-31→ common stock (971,324 underlying)
Award
stock option
2004-09-20+49,854→ 49,854 total
Exercise: $0.38Exp: 2006-09-19→ common stock (49,854 underlying)

Footnotes (9)

[F1]received shares through distribution from Tomson Voting Trust
[F2]the high bid price for the common shares of Viral Genetics, Inc., on the over-the-counter market on the date of distribution was $0.45
[F3]Received in exchange for capital stock of Therapeutic Genetic, Inc., in connection with merger of Therapeutic Genetic, Inc. into subsidiary of Viral Genetics, Inc. On September 20, 2004, the high bid price for Viral Genetics, Inc. common stock in the over-the-counter market was $0.38.
[F4]note assigned to Best Investments, Inc.
[F5]immediately
[F6]not applicable
[F7]The warrants were issued with common stock of Viral Genetics, Inc., in the merger transaction that resulted in the acquisition of Therapeutic Genetic, Inc.
[F8]granted pursuant to Employment Agreement
[F9]All stock options with a transaction date of 09/20/2004 are options originally granted to Therapeutic Genetic, Inc. and distributed by Therapeutic Genetic, Inc. to its shareholders for no consideration immediately prior to the merger of Therapeutic Genetic, Inc. with the subsidiary of Viral Genetics, Inc.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

VIRAL GENETICS INC /DE/

CIK 0001091326

Entity typeother

Related Parties

1

filerCIK 0001278333

Filing Metadata

Form type: 4
Filed: Oct 21, 8:00 PM ET
Accepted: Oct 22, 2:08 PM ET
Size: 22.7 KB

View on SEC.gov